Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10080743 Isoxazole derivatives as FXR agonists and methods of use thereof

Patent 10080743 was granted and assigned to Enanta Pharmaceuticals on September, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100807430

Patent Inventor Names

Yong He0

Ruichao Shen0

Xuechao Xing0

Yat Sun Or0

Bin Wang0

Brett Granger0

Guoqiang Wang0

Jiang Long0

...

Date of Patent

September 25, 2018

Patent Application Number

154973590

Date Filed

April 26, 2017

Patent Citations Received

‌

US Patent 11555032 Isoxazole derivatives as FXR agonists and methods of use thereof

‌

US Patent 11332450 Isoxazole as FXR receptor agonists

‌

US Patent 10562910 Nitrogen-containing tricyclic compounds and uses thereof in medicine

Patent Primary Examiner

‌

Laura L. Stockton

Patent abstract

The present invention provides compounds of Formula I,

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10080743 Isoxazole derivatives as FXR agonists and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API